Company page
Compugen Ltd.
Compugen Ltd. is a public company traded under the ticker CGEN in the American market. The company has a market capitalization of approximately $224 million. Compugen focuses on developing innovative therapeutic solutions in the field of immuno-oncology.
- Ticker
- CGEN:NASDAQ
- Asset type
- Stock
- Market cap
- $246.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD